The U.S. Centers for Disease Control and Prevention (CDC) released data on May 29 showing that drug overdose deaths in 2025 fell nearly 14% from the previous year, continuing a downward trend for the third consecutive year. The estimated number of deaths in 2025 is about 70,000, down sharply from over 81,000 in 2024.
The peak of the crisis occurred during the COVID-19 pandemic, when 110,000 deaths were recorded in 2022, driven largely by social isolation and reduced access to treatment services. The synthetic opioid fentanyl is considered a key factor worsening the situation.
Brandon Marshall, a researcher at Brown University who tracks overdose trends, expressed cautious optimism: “I believe this represents a fundamental shift in the trajectory of the overdose crisis.”
Experts attribute the decline to multiple factors, including expanded access to naloxone (often sold under the brand name Narcan) used to reverse overdoses; wider availability of fentanyl test strips; and regulatory changes in China that restrict fentanyl precursor chemicals.
While deaths fell in most states, seven states reported increases, with Arizona, Colorado, and New Mexico seeing gains of 10% or more. The administration of President Donald Trump cited the overall decline as evidence of its crackdown on drug crime. The White House emphasized that overdose remains one of the “most urgent” public health challenges.
FBI Director Kash Patel said that in 2025 and 2026, the agency had seized enough fentanyl to kill more than 200 million Americans (over half the country’s population). Former Attorney General Pam Bondi previously claimed that drug seizure data from the first 100 days of the Trump administration had “saved 119 million lives,” later raising that figure to 258 million. However, experts say these claims are grossly exaggerated.
The Trump administration also cut overdose prevention programs, such as stopping funding for test strips that help users detect fentanyl in drugs, a move criticized by activists.
